Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBIAT: 2013-2018

Historic EBIAT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' EBIAT rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 23.75%. This contributed to the annual value of -$18.9 million for FY2024, which is 72.60% up from last year.
  • According to the latest figures from Q4 2018, Armata Pharmaceuticals' EBIAT is -$1.1 million, which was up 60.27% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year EBIAT high stood at $21.2 million for Q3 2014, and its period low was -$14.5 million during Q1 2015.
  • Its 3-year average for EBIAT is -$4.1 million, with a median of -$3.1 million in 2016.
  • Within the past 5 years, the most significant YoY rise in Armata Pharmaceuticals' EBIAT was 194.74% (2014), while the steepest drop was 587.36% (2014).
  • Armata Pharmaceuticals' EBIAT (Quarterly) stood at -$664,000 in 2014, then plummeted by 235.99% to -$2.2 million in 2015, then tumbled by 325.82% to -$9.5 million in 2016, then spiked by 75.24% to -$2.4 million in 2017, then spiked by 53.19% to -$1.1 million in 2018.
  • Its last three reported values are -$1.1 million in Q4 2018, -$2.8 million for Q3 2018, and -$9.7 million during Q2 2018.